Company logo

ARAY - Accuray Incorporated

NASDAQ -> Healthcare -> Medical Devices
Sunnyvale, United States
Type: Equity

ARAY price evolution
ARAY
(in millions $) 1 May 2024 31 Jan 2024 30 Oct 2023 30 Jul 2023
Current assets
Cash $74.49 $78.69 $91.2
Short term investments
Net receivables $77.4 $77.37 $74.78
Inventory $155.23 $149.98 $145.15
Total current assets $331.17 $334.15 $338.03
Long term investments $14.54 $13.12 $15.13
Property, plant & equipment $49.01 $49.34 $46.78
Goodwill & intangible assets $57.89 $57.82 $57.89
Total noncurrent assets $145.18 $142.68 $141.18
Total investments $14.54 $13.12 $15.13
Total assets $476.35 $476.83 $479.21
Current liabilities
Accounts payable $39.18 $34.88 $33.74
Deferred revenue $102.22 $98.7 $99.26
Short long term debt $12.45 $12.31 $9.87
Total current liabilities $209.31 $201.45 $198.64
Long term debt $189.78 $192.6 $171.56
Total noncurrent liabilities $219.39 $224.44 $226.92
Total debt $202.22 $204.9 $205.04
Total liabilities $428.7 $425.89 $425.56
Shareholders' equity
Retained earnings -$514.73 -$505.11 -$502.14
Other shareholder equity $1.06 -$1.72 $0.42
Total shareholder equity $47.65 $50.94 $53.66
(in millions $) 31 Jan 2024 31 Dec 2022 31 Dec 2021 31 Dec 2020
Current assets
Cash $91.2 $90.15 $118.2 $109.91
Short term investments
Net receivables $74.78 $94.44 $85.36 $90.6
Inventory $145.15 $142.25 $125.93 $134.37
Total current assets $338.03 $350.89 $352.77 $357.49
Long term investments $15.13 $13.88 $15.94 $13.93
Property, plant & equipment $46.78 $29.48 $34.85 $44
Goodwill & intangible assets $57.89 $58.09 $58.4 $58.38
Total noncurrent assets $141.18 $121.96 $127.33 $133.44
Total investments $15.13 $13.88 $15.94 $13.93
Total assets $479.21 $472.85 $480.1 $490.93
Current liabilities
Accounts payable $33.74 $31.34 $19.47 $23.13
Deferred revenue $99.26 $100.07 $105.34 $107.33
Short long term debt $9.87 $17.13 $11.96 $8.22
Total current liabilities $198.64 $208.86 $192.36 $182.27
Long term debt $171.56 $182.36 $187.45 $213.48
Total noncurrent liabilities $226.92 $210.8 $218.9 $245.02
Total debt $205.04 $199.49 $199.41 $221.7
Total liabilities $425.56 $419.66 $411.26 $427.29
Shareholders' equity
Retained earnings -$502.14 -$492.52 -$488.02 -$481.71
Other shareholder equity $0.42 $2.41 $2.09 -$0.48
Total shareholder equity $53.66 $53.19 $68.84 $63.63
(in millions $) 1 May 2024 31 Jan 2024 30 Oct 2023 30 Jul 2023
Revenue
Total revenue $118.29
Cost of revenue
Gross Profit $37.68
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $38.13
Operating income
Income from continuing operations
EBIT
Income tax expense $0.58
Interest expense $1.61
Net income
Net income -$2.56
Income (for common shares)
(in millions $) 31 Jan 2024 31 Dec 2022 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $429.91 $396.29 $382.93
Cost of revenue $269.95 $236.78 $233.21
Gross Profit $159.96 $159.51 $149.72
Operating activities
Research & development $57.75 $52.73 $49.78
Selling, general & administrative $94.06 $84.54 $87.4
Total operating expenses $151.81 $137.27 $137.18
Operating income $8.15 $22.23 $12.54
Income from continuing operations
EBIT -$2 -$4.56 $5.69
Income tax expense $3.35 $1.75 $1.86
Interest expense
Net income
Net income -$5.35 -$6.31 $3.83
Income (for common shares) -$5.35 -$6.31 $3.83
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$9.62 -$2.97 -$2.56 $0.6
Operating activities
Depreciation $1.55 $1.25 $1.1 $1.1
Business acquisitions & disposals $0.06 -$0.06
Stock-based compensation $2.31 $2.39 $2.45 $1.56
Total cash flows from operations -$5.09 -$8.59 $8.88 $24.63
Investing activities
Capital expenditures -$1.25 -$1.09 -$8.04 -$1.77
Investments
Total cash flows from investing -$1.25 -$1.09 -$7.98 -$1.9
Financing activities
Dividends paid
Sale and purchase of stock $1.36 $1.06
Net borrowings -$1.5 -$1.5 -$1.5 -$1.5
Total cash flows from financing -$0.26 -$1.5 -$0.52 -$1.5
Effect of exchange rate $2.4 -$1.33 -$0.03 $0.41
Change in cash and equivalents -$4.2 -$12.51 $0.35 $21.64
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$9.28 -$5.35 -$6.31 $3.83
Operating activities
Depreciation $4.53 $5.51 $6.39 $7.54
Business acquisitions & disposals -$0.08
Stock-based compensation $10.05 $10.6 $9.33 $8.15
Total cash flows from operations $15.54 -$2.4 $38.51 -$1.47
Investing activities
Capital expenditures -$12.61 -$4.72 -$2.32 -$3.56
Investments
Total cash flows from investing -$12.68 -$4.72 -$2.4 -$3.73
Financing activities
Dividends paid
Sale and purchase of stock $2.2 $3.89 -$11.05 $2.45
Net borrowings -$4.11 -$19 -$17.41 $24.45
Total cash flows from financing -$2.11 -$15.37 -$28.8 $26.7
Effect of exchange rate $0.3 -$5.56 $0.98 $0.23
Change in cash and equivalents $1.05 -$28.05 $8.29 $21.73
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 7.93
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A